Ultime notizie per Archrock (NYSE:AROC) Azioni

Archrock

Archrock Inc is an energy infrastructure company with a focus on midstream natural gas compression and a commitment to helping customers produce, compress, and transport natural gas. It has two business segments, Contract Operations, and Aftermarket Services. Under the umbrella of contract operations services, the company provides operations to meet customers' natural gas compression needs. Services include designing, owning, installing, operating, and maintaining equipment. Aftermarket Services business provides a full range of services to support the compression needs of customers who own compression equipment, including operations, maintenance, overhaul, and reconfiguration services, and sales of parts and components. It generates maximum revenue from the Contract Operations segment.

Archrock Inc

WIIM

UnitedHealth shares are trading lower after the Wall Street Journal reported DOJ prosecutors are questioning doctors about the company's Medicare billing practices.

AES shares are trading higher after Bloomberg reported the company is exploring options amid takeover interest.

D. Boral Capital analyst Jason Kolbert maintains VolitionRX (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VNRX#AMEX">VNRX</a>) with a Buy and maintains $5 price target.

News

Price Target

Analyst Ratings

VNRX

D. Boral Capital Maintains Buy on VolitionRX, Maintains $5 Price Target

IONQ

IonQ Selected by KISTI as Primary Quantum Partner as South Korea Secures Funding for First National Quantum Center

TD Cowen analyst John Kernan downgrades PVH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>) from Buy to Hold and lowers the price target from $98 to $74.

Downgrades

TD Cowen Downgrades PVH to Hold, Lowers Price Target to $74

PLTR

Palantir Partners With Tomorrow.io To Deliver Agentic AI And Global Weather Intelligence For Defense, Government, And Enterprise

SBUX

Starbucks shares are trading higher following reports suggesting the company has drawn interest from potential investors regarding its China business.

TD Cowen analyst Kyle Bauser initiates coverage on Bio-Techne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TECH#NASDAQ">TECH</a>) with a Buy rating and announces Price Target of $65.

Initiation

TECH

TD Cowen Initiates Coverage On Bio-Techne with Buy Rating, Announces Price Target of $65

Triple Flag Precious Metals Corp. (with its subsidiaries, "Triple Flag" or the "Company") (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TFPM#TSX">TFPM</a>, NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFPM#NYSE">TFPM</a>) announced record revenue of US$94.1 million for the second quarter of 2025 from quarterly metal sales of 28,682 gold equivalent ounces ("GEOs"). All dollar amounts are expressed in US dollars, unless otherwise noted.
"Triple Flag achieved another quarter of record revenue, driven by record performance from Northparkes. Following a strong first half of the year, we remain on track to deliver our 2025 GEOs guidance of 105,000 to 115,000 ounces," commented Sheldon Vanderkooy, CEO. "We expect our transaction with Orogen Royalties to close imminently, which will result in Triple Flag's acquisition of a 1.0% NSR royalty on AngloGold Ashanti's Arthur gold project1 in Nevada. Arthur is a tier one gold asset that we expect will drive significant additional long-term GEOs growth."

TFPM

TSX:TFPM

Triple Flag Reports Q2 Revenue Of $94.1M From Quarterly Metal Sales Of 28,682 Gold Equivalent Ounces

Ripple Selects BNY Mellon As Primary Custodian For Ripple USD (RLUSD) Reserves To Support Institutional-Scale Stablecoin Adoption

Primis, the video discovery platform for publishers and part of the McCann and IPG network (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPG#NYSE">IPG</a>), has signed an exclusive partnership with Absolute Sports, the global digital media group behind <a href="http://sportskeeda.com/">Sportskeeda.com</a>,&nbsp;and other leading brands. With over 80 million monthly users and reach across 150+ countries, Absolute Sports is a leading force in global digital sports media.
&nbsp;
As part of the partnership, the&nbsp;Primis online video player has been fully integrated across all Absolute Sports websites. This lightweight video technology fits seamlessly within editorial environments, surfacing original video content in context. The result is a non-intrusive viewing experience that encourages users to keep exploring. It guides them naturally from one story to the next and creates a self-contained discovery journey that keeps audiences immersed in the brand experience.

IPG-Owned Primis Teams Up With Sportskeeda Parent to Power Video Discovery for 80M Global Sports Fans

Contracts

GILT

Gilat Commercial Division Receives Over $22M In Orders From Satellite Operators, Scheduled For Delivery Over Next 12 Months

<ul>
<li>NMRA-861 has potential best-in-class pharmacology, which may enable a more favorable therapeutic profile</li>
<li>No convulsions observed in pre-clinical studies conducted in multiple species, including rabbits</li>
</ul>

NMRA

Neumora Therapeutics Begins Phase 1 Clinical Trial Of NMRA-861, A Selective M4 Positive Allosteric Modulator For Schizophrenia

Autozi Receives Nasdaq Notification For Failing To Meet $50M Market Value Requirement; Has Until Jan 5, 2026 To Regain Compliance

TD Cowen analyst Bill Katz downgrades LPL Finl Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPLA#NASDAQ">LPLA</a>) from Buy to Hold and lowers the price target from $406 to $403.

LPLA

TD Cowen Downgrades LPL Finl Hldgs to Hold, Lowers Price Target to $403

Through the agreement, Redwire and SpaceData will focus on the following areas of collaboration:
<ul>
<li>Identify opportunities to integrate SpaceData into Redwire's digital ecosystem to support current and future missions to the International Space Station (ISS);</li>
<li>Explore combined solutions to pursue opportunities to support NASA Commercial Low Earth Orbit (LEO) Destination utilization components, systems, and software;</li>
<li>Explore future collaborations for Cislunar, Lunar and Deep Space missions and services; and</li>
<li>Redwire will look to leverage SpaceData's artificial intelligence (AI) for space and robotics capabilities.</li>
</ul>

General

Redwire Signs MoU With Japanese Startup SpaceData For Collaborations On Artificial Intelligence And Digital Engineering Systems

Parsons Subsidiary SealingTech Teams Up With NCS To Expand Cyber Hunt Kit Production For Defense Agencies

&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4464805-1&amp;h=3813736257&amp;u=https%3A%2F%2Fwww.galaxy.com%2F&amp;a=Galaxy+Digital+Inc.">Galaxy Digital Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLXY#NASDAQ">GLXY</a>) (TSX:<a class="ticker" href="https://www.benzinga.com/stock/GLXY#TSX">GLXY</a>)&nbsp;announced today that it has integrated with <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4464805-1&amp;h=3593130843&amp;u=https%3A%2F%2Fwww.fireblocks.com%2F&amp;a=Fireblocks">Fireblocks</a>, the leading digital asset and payments infrastructure platform for moving, storing, and issuing digital assets. This collaboration significantly broadens access to Galaxy's staking services by connecting to Fireblocks' global network of institutions that rely on its battle-tested digital asset security platform.
&nbsp;
With this integration, Galaxy's staking services are now natively accessible to more than 2,000 of the world's largest financial institutions that use Fireblocks to securely manage digital assets. Clients can stake digital assets directly from their Fireblocks vaults – without moving assets off-platform – while leveraging Galaxy's high-performance, globally-distributed validator infrastructure.
This collaboration allows institutions to participate in secure, scalable staking while exploring advanced strategies that tap into Galaxy's integrated trading and lending solutions, transforming passive staking into a capital-efficient, reward-generating strategy.

GLXY

TSX:GLXY

Galaxy Digital Opens Staking Access to 2,000+ Institutions Through Fireblocks Integration

SMTK

Smartkem Enters Preliminary Joint Development Agreement With Manz Asia To Co-Develop Dielectric Ink Solutions For AI Chip Packaging

Arvinas, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARVN#NASDAQ">ARVN</a>), a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein degradation, today&nbsp;announced that John Houston, Ph.D., Chairperson, Chief Executive Officer (CEO) and President at Arvinas, has informed the Board of Directors of his plans to retire from his role as President and CEO following a search for, and the appointment of, the Company's new CEO. The Arvinas Board of Directors has begun a search for a new CEO, and Dr. Houston will remain Chairperson of Arvinas' Board of Directors upon retiring as President and CEO.
"On behalf of the Arvinas Board of Directors, I sincerely thank John for his exceptional leadership and significant contributions to Arvinas over the past 8 years and his commitment to a smooth transition as we identify his successor," said Briggs Morrison, M.D., Arvinas Board Member and Lead Independent Director. "John has guided Arvinas through a substantial number of ‘firsts' for PROTACs in the industry, from the first to enter the clinic to the first positive pivotal Phase 3 trial and the first new drug application. John and Arvinas have turned targeted protein degradation into a well-known modality across several therapeutic areas. Due to his efforts, the Company is well positioned to benefit many patients in the years to come. As we undertake the process of identifying a new CEO, the Board is committed to conducting a thoughtful search to ensure continued strong leadership. We look forward to continuing our work with John in his capacity as Chairperson."
With more than 35 years of experience in the pharmaceutical and biotech industries, Dr. Houston joined Arvinas in January 2017 as President of Research and Development and Chief Scientific Officer responsible for leading the discovery, translational, and early clinical development research efforts. In September 2017, Dr. Houston was appointed President and CEO, and in 2023 he was named Arvinas' Chairperson.
During his tenure as CEO, Dr. Houston has been instrumental in Arvinas' success moving six programs into the clinic, reporting the results of the first positive pivotal Phase 3 trial for a PROTAC, and reporting for the first time that an orally administered PROTAC can achieve pharmacodynamic activity in the central nervous system.
"It has been an honor to lead Arvinas alongside incredibly talented colleagues and a supportive Board of Directors," said Dr. Houston. "I look forward to remaining a part of Arvinas as Chairperson and I'm confident in the Company's ability to improve the lives of patients with serious diseases through our revolutionary PROTAC protein degradation platform. From initiating the first oral PROTAC degrader in clinical trials to delivering positive topline results, it is evident that Arvinas has and will continue to push the boundaries of what's possible."

Management

ARVN

Arvinas Begins CEO Search as Longtime Leader John Houston Plans Exit From Top Role, Will Stay On as Board Chair

Earnings

Press Releases

Archrock Reports Third Quarter 2024 Results and Raises Full Year 2024 Financial Guidance

Dividends

Archrock Increases Quarterly Cash Dividend

Archrock Announces Timing for Fourth Quarter 2024 Results

Archrock Reports Fourth Quarter and Full Year 2024 Results and Provides 2025 Guidance

Coldstream Energy Launches the MaCH4™ NGL Recovery Solution with Archrock as Strategic Distribution Partner

Archrock to Acquire Natural Gas Compression Systems, Inc.

Archrock Announces Quarterly Cash Dividend

Archrock Announces Timing for First Quarter 2025 Results

Archrock Completes Acquisition of Natural Gas Compression Systems, Inc.

Archrock Reports First Quarter 2025 Results

AROC

ProFrac Holding Corp. - Class A Common Stock

ProFrac Holding

Atlas Energy Solutions

Aris Water Solutions, Inc. Class A Common Stock

Aris Water Solutions

Baker Hughes

ChampionX

Flowco Holdings Inc. Class A Common Stock

Flowco Holdings

TechnipFMC

Halliburton

Helix Energy Solutions Group, Inc. Common Stock

Helix Energy Solns Gr

Innovex International

Kodiak Gas Services

Liberty Energy

Oceaneering International, Inc. Common Stock

Oceaneering International

ProPetro Holding

Solaris Energy Infrastructure, Inc. Class A Common Stock

Solaris Energy

Tidewater

Tenaris

USA Compression Partners, LP Common Units Representing Limited Partner Interests

Comments

Archrock

Notizie

Ultime notizie per Archrock (NYSE:AROC) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO